Literature DB >> 27328801

Meta-analysis and systematic review of procalcitonin-guided treatment in acute exacerbation of chronic obstructive pulmonary disease.

Changyang Lin1, Qiyuan Pang1.   

Abstract

INTRODUCTION: To evaluate the method of procalcitonin (PCT)-guided treatment on antibiotics in acute exacerbation of chronic obstructive pulmonary disease (AECOPD).
METHODS: Database including PubMed, EMBASE, and the Cochrane Central Register of Controlled Trails were searched to find relevant trails. Randomized and quasi-randomized trials of PCT-guided treatment in adult patients with AECOPD were included. Effects on primary outcome (i.e., antibiotic prescriptions, mortality, and clinical success) were accessed in this meta-analysis.
RESULTS: Four trials involving 679 patients were included. PCT-guided treatment significantly reduced antibiotic use (OR 0.26, 95% CI 0.14-0.50, P < 0.0001) in comparison to standard treatment, without increasing clinical failure (OR 1.10, 95% CI 0.70-1.74, P = 0.68; I2  = 0%) and mortality (OR 0.86, 95% CI 0.44-1.68, P = 0.66). The rate of readmission and exacerbation at follow-up period was similar in both groups.
CONCLUSION: Results from this meta-analysis suggest PCT-guided treatment can safely reduce antibiotic overuse in patients with AECOPD.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  AECOPD; antibiotics; meta-analysis; procalcitonin

Mesh:

Substances:

Year:  2016        PMID: 27328801     DOI: 10.1111/crj.12519

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  9 in total

Review 1.  Biomarker-guided antibiotic therapy-strengths and limitations.

Authors:  David Nora; Jorge Salluh; Ignacio Martin-Loeches; Pedro Póvoa
Journal:  Ann Transl Med       Date:  2017-05

2.  Sepsis Biomarkers.

Authors:  Yachana Kataria; Daniel Remick
Journal:  Methods Mol Biol       Date:  2021

Review 3.  The recent advances of phenotypes in acute exacerbations of COPD.

Authors:  Aiyuan Zhou; Zijing Zhou; Yiyang Zhao; Ping Chen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-03-27

4.  Procalcitonin-guided antibiotic therapy in acute exacerbation of chronic obstructive pulmonary disease: An updated meta-analysis.

Authors:  Zhuying Li; Xingxing Yuan; Ling Yu; Bingyu Wang; Fengli Gao; Jian Ma
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

5.  Measurement of Procalcitonin as an Indicator of Severity in Patients With Chronic Obstructive Pulmonary Disease Admitted With Respiratory Illness.

Authors:  Alexander J Davies; Paul W Blessing; Wesley P Eilbert
Journal:  Cureus       Date:  2022-08-28

6.  Antibiotics for exacerbations of chronic obstructive pulmonary disease.

Authors:  Daniela J Vollenweider; Anja Frei; Claudia A Steurer-Stey; Judith Garcia-Aymerich; Milo A Puhan
Journal:  Cochrane Database Syst Rev       Date:  2018-10-29

Review 7.  The Use of Serum Procalcitonin as a Diagnostic and Prognostic Biomarker in Chronic Obstructive Pulmonary Disease Exacerbations: A Literature Review Update.

Authors:  Nikolaos-Dimitrios Pantzaris; Diamantina-Xanthi Spilioti; Aikaterini Psaromyalou; Ioanna Koniari; Dimitrios Velissaris
Journal:  J Clin Med Res       Date:  2018-06-04

Review 8.  Appropriate antibiotic management of bacterial lower respiratory tract infections.

Authors:  Charles Feldman; Guy Richards
Journal:  F1000Res       Date:  2018-07-23

Review 9.  A 2020 review on the role of procalcitonin in different clinical settings: an update conducted with the tools of the Evidence Based Laboratory Medicine.

Authors:  Anna Maria Azzini; Romolo Marco Dorizzi; Piersandro Sette; Marta Vecchi; Ilaria Coledan; Elda Righi; Evelina Tacconelli
Journal:  Ann Transl Med       Date:  2020-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.